vs
Side-by-side financial comparison of Royalty Pharma plc (RPRX) and Bristow Group Inc. (VTOL). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $377.3M, roughly 1.6× Bristow Group Inc.). Royalty Pharma plc runs the higher net margin — 34.4% vs 4.9%, a 29.6% gap on every dollar of revenue. On growth, Bristow Group Inc. posted the faster year-over-year revenue change (6.7% vs 4.8%). Over the past eight quarters, Bristow Group Inc.'s revenue compounded faster (5.8% CAGR vs 4.6%).
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
Bristow Helicopters Limited is a British civil helicopter operator originally based at Aberdeen Airport, Scotland, which is currently a part of the U.S.-based Bristow Group which in turn has its corporate headquarters in Houston, Texas, U.S. In 2020, Bristow Group was merged with Era Helicopters, a large U.S.-based commercial helicopter operator that was previously a division of Era Aviation, with the two companies then continuing to use the Bristow name.
RPRX vs VTOL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $622.0M | $377.3M |
| Net Profit | $214.2M | $18.4M |
| Gross Margin | — | — |
| Operating Margin | 62.4% | 8.5% |
| Net Margin | 34.4% | 4.9% |
| Revenue YoY | 4.8% | 6.7% |
| Net Profit YoY | 2.9% | -42.1% |
| EPS (diluted) | $0.49 | $0.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $622.0M | $377.3M | ||
| Q3 25 | $609.3M | $386.3M | ||
| Q2 25 | $578.7M | $376.4M | ||
| Q1 25 | $568.2M | $350.5M | ||
| Q4 24 | $593.6M | $353.5M | ||
| Q3 24 | $564.7M | $365.1M | ||
| Q2 24 | $537.3M | $359.7M | ||
| Q1 24 | $568.0M | $337.1M |
| Q4 25 | $214.2M | $18.4M | ||
| Q3 25 | $288.2M | $51.5M | ||
| Q2 25 | $30.2M | $31.7M | ||
| Q1 25 | $238.3M | $27.4M | ||
| Q4 24 | $208.2M | $31.8M | ||
| Q3 24 | $544.0M | $28.2M | ||
| Q2 24 | $102.0M | $28.2M | ||
| Q1 24 | $4.8M | $6.6M |
| Q4 25 | 62.4% | 8.5% | ||
| Q3 25 | 70.1% | 13.1% | ||
| Q2 25 | 36.3% | 11.3% | ||
| Q1 25 | 94.0% | 9.6% | ||
| Q4 24 | 60.9% | 9.0% | ||
| Q3 24 | — | 9.1% | ||
| Q2 24 | 50.2% | 12.4% | ||
| Q1 24 | -13.0% | 6.8% |
| Q4 25 | 34.4% | 4.9% | ||
| Q3 25 | 47.3% | 13.3% | ||
| Q2 25 | 5.2% | 8.4% | ||
| Q1 25 | 41.9% | 7.8% | ||
| Q4 24 | 35.1% | 9.0% | ||
| Q3 24 | 96.3% | 7.7% | ||
| Q2 24 | 19.0% | 7.8% | ||
| Q1 24 | 0.8% | 2.0% |
| Q4 25 | $0.49 | $0.61 | ||
| Q3 25 | $0.67 | $1.72 | ||
| Q2 25 | $0.07 | $1.07 | ||
| Q1 25 | $0.55 | $0.92 | ||
| Q4 24 | $0.46 | $1.07 | ||
| Q3 24 | $1.21 | $0.95 | ||
| Q2 24 | $0.23 | $0.96 | ||
| Q1 24 | $0.01 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $618.7M | $286.2M |
| Total DebtLower is stronger | $9.0B | $671.5M |
| Stockholders' EquityBook value | $9.7B | $1.1B |
| Total Assets | $19.6B | $2.3B |
| Debt / EquityLower = less leverage | 0.92× | 0.63× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $618.7M | $286.2M | ||
| Q3 25 | $938.9M | $245.5M | ||
| Q2 25 | $631.9M | $251.8M | ||
| Q1 25 | $1.1B | $191.1M | ||
| Q4 24 | $929.0M | $247.5M | ||
| Q3 24 | $950.1M | $200.3M | ||
| Q2 24 | $1.8B | $178.6M | ||
| Q1 24 | $843.0M | $140.6M |
| Q4 25 | $9.0B | $671.5M | ||
| Q3 25 | $8.9B | $675.0M | ||
| Q2 25 | $8.0B | $705.2M | ||
| Q1 25 | $7.6B | $701.9M | ||
| Q4 24 | $7.6B | $689.8M | ||
| Q3 24 | $7.6B | $629.1M | ||
| Q2 24 | $7.6B | $594.2M | ||
| Q1 24 | $6.1B | $544.1M |
| Q4 25 | $9.7B | $1.1B | ||
| Q3 25 | $9.6B | $1.0B | ||
| Q2 25 | $9.5B | $984.4M | ||
| Q1 25 | $9.8B | $931.7M | ||
| Q4 24 | $10.3B | $891.7M | ||
| Q3 24 | $10.3B | $899.2M | ||
| Q2 24 | $9.8B | $849.1M | ||
| Q1 24 | $9.9B | $820.7M |
| Q4 25 | $19.6B | $2.3B | ||
| Q3 25 | $19.3B | $2.3B | ||
| Q2 25 | $18.3B | $2.3B | ||
| Q1 25 | $17.6B | $2.2B | ||
| Q4 24 | $18.2B | $2.1B | ||
| Q3 24 | $18.0B | $2.1B | ||
| Q2 24 | $17.7B | $2.0B | ||
| Q1 24 | $16.1B | $1.9B |
| Q4 25 | 0.92× | 0.63× | ||
| Q3 25 | 0.93× | 0.65× | ||
| Q2 25 | 0.84× | 0.72× | ||
| Q1 25 | 0.78× | 0.75× | ||
| Q4 24 | 0.74× | 0.77× | ||
| Q3 24 | 0.74× | 0.70× | ||
| Q2 24 | 0.78× | 0.70× | ||
| Q1 24 | 0.62× | 0.66× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $827.1M | $76.9M |
| Free Cash FlowOCF − Capex | — | $47.8M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 7.7% |
| Cash ConversionOCF / Net Profit | 3.86× | 4.17× |
| TTM Free Cash FlowTrailing 4 quarters | — | $56.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $827.1M | $76.9M | ||
| Q3 25 | $702.6M | $23.1M | ||
| Q2 25 | $364.0M | $99.0M | ||
| Q1 25 | $596.1M | $-603.0K | ||
| Q4 24 | $742.5M | $51.1M | ||
| Q3 24 | $703.6M | $66.0M | ||
| Q2 24 | $658.2M | $33.7M | ||
| Q1 24 | $664.6M | $26.7M |
| Q4 25 | — | $47.8M | ||
| Q3 25 | — | $-6.2M | ||
| Q2 25 | — | $67.4M | ||
| Q1 25 | — | $-52.7M | ||
| Q4 24 | — | $-32.4M | ||
| Q3 24 | — | $9.0M | ||
| Q2 24 | — | $-16.7M | ||
| Q1 24 | — | $-37.9M |
| Q4 25 | — | 12.7% | ||
| Q3 25 | — | -1.6% | ||
| Q2 25 | — | 17.9% | ||
| Q1 25 | — | -15.0% | ||
| Q4 24 | — | -9.2% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -11.2% |
| Q4 25 | — | 7.7% | ||
| Q3 25 | — | 7.6% | ||
| Q2 25 | — | 8.4% | ||
| Q1 25 | — | 14.9% | ||
| Q4 24 | — | 23.6% | ||
| Q3 24 | — | 15.6% | ||
| Q2 24 | — | 14.0% | ||
| Q1 24 | — | 19.2% |
| Q4 25 | 3.86× | 4.17× | ||
| Q3 25 | 2.44× | 0.45× | ||
| Q2 25 | 12.06× | 3.12× | ||
| Q1 25 | 2.50× | -0.02× | ||
| Q4 24 | 3.57× | 1.61× | ||
| Q3 24 | 1.29× | 2.34× | ||
| Q2 24 | 6.45× | 1.20× | ||
| Q1 24 | 139.10× | 4.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
VTOL
| Offshore Energy Services | $247.5M | 66% |
| Government Services | $100.1M | 27% |
| Other | $21.9M | 6% |
| Related Party | $7.8M | 2% |
